Researcher
Michel Koole
- Disciplines:Medical imaging and therapy, Medicinal products
Affiliations
- Nuclear Medicine & Molecular Imaging (Division)
Member
From1 Jan 2007 → Today
Projects
11 - 20 of 21
- BEyOND: Brain pEt to Overcome Neurodegenerative Diseases.From15 Apr 2019 → 14 Apr 2021Funding: BOF - various
- Deep Learning Models for the Detection and Segmentation of Tumoral Lesions Using PET and MRIFrom1 Mar 2018 → 4 Oct 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Synaptic density, tau and multiparametric PET-MR for quantitative functional assessment and prognosis in stroke and mild cognitive impairmentFrom1 Jan 2018 → 31 Dec 2021Funding: FWO research project (including WEAVE projects)
- PET/MR imaging and quantification of neuroinflammation, tau and synaptic density in neurodegenerative diseasesFrom1 Jan 2018 → 31 Dec 2021Funding: FWO Strategic Basic Research Grant
- Synaptic density, tau and multiparametric PET-MR for quantitative functional assessment and prognosis in acute and repetitive brain trauma, stroke and mild cognitive impairmentFrom1 Oct 2017 → 30 Sep 2022Funding: BOF - Concerted Research Project from 1994
- Innovative Training Network towards raising and supporting the next generation of creative and entrepreneurial cross-speciality imaging expertsFrom1 Oct 2017 → 30 Sep 2021Funding: H2020 - Skills and Career Development (Marie Skłodowska-Curie) actions, Activities of International Cooperation
- Multimodal image processing and data management platformFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- A high-resolution and high-sensitivity hybrid small animal PET-CT system for combined molecular/functional and anatomical preclinical imaging in neurology, oncology and cardiology.From1 May 2016 → 30 Apr 2020Funding: FWO Medium Size Research Infrastructure
- Multimodal view on brain connectivity with simultaneous PET/MRFrom1 Feb 2016 → 31 Dec 2020Funding: FWO Strategic Basic Research Grant
- An optical imaging system for in vivo bioluminescent and fluorescent imaging in small laboratory animals.From26 Apr 2012 → 25 Oct 2018Funding: Hercules - Small and Medium size research infrastructure
Publications
1 - 10 of 186
- Comparison of a 3D CZT and conventional SPECT/CT system for quantitative Lu-177 SPECT imaging.(2024)
Authors: Georg Schramm, Michel Koole
Pages: 29 - Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging.(2024)
Authors: Tom Van Loy, Christophe Deroose, Michel Koole, Dominique Schols, Frederik Cleeren
Pages: 108906 - Preliminary evidence for preserved synaptic density in late-life depression(2024)
Authors: Thomas Vande Casteele, Maarten Laroy, Margot Van Cauwenberge, Michel Koole, Patrick Dupont, Jan Van den Stock, Filip Bouckaert, Koen Van Laere, Louise Emsell, Mathieu Vandenbulcke
- Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside(2024)
Authors: Michel Koole, Christophe Deroose, Kristof Baete, Thomas Elias Cocolios, Frederik Cleeren
Pages: 1720 - 1743 - Tau Imaging in Late Traumatic Brain Injury: A [18F]MK-6240 Positron Emission Tomography Study(2024)
Authors: Greet Vanderlinden, Michel Koole, Robin Lemmens, Bart Depreitere, Mathieu Vandenbulcke, Koen Van Laere
Pages: 420 - 429 - PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management(2024)
Authors: Alexander Giesen, Steven Joniau, Koen Van Laere, Michel Koole, Christophe Deroose, Karolien Goffin
Pages: 31 - 54 - The revision of the pharmaceutical legislation - it is time to act for nuclear medicine in Europe(2023)
Authors: Michel Koole
Pages: 20 - 24 - Uncertainty analysis for Lu-177-PSMA in clinical routine(2023)
Authors: Michel Koole
Pages: S192 - S192 - Impact on clinical management when using [18F]AlFNOTA-octreotide instead of [68Ga]Ga-DOTA-SSA PET/CT in neuroendocrine tumor patients: preliminary results(2023)
Authors: Jeroen Dekervel, Frederik Cleeren, Michel Koole, Guy Bormans, Chris Verslype, Christophe Deroose
Pages: S508 - S508 - PET/MRI in practice: a clinical centre survey endorsed by the European Association of Nuclear Medicine (EANM) and the EANM Forschungs GmbH (EARL)(2023)
Authors: Michel Koole
Pages: 2927 - 2934